naphthalimides has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Chen, Z; Hu, Y; Liu, Y; Wang, J; Wu, S; Xue, J; Yang, F; Yang, Y; Zheng, M; Zhou, X; Zhu, H | 1 |
1 other study(ies) available for naphthalimides and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
MEAN inhibits hepatitis C virus replication by interfering with a polypyrimidine tract-binding protein.
Topics: Antiviral Agents; Cell Death; Cell Line, Tumor; Cytoplasm; Down-Regulation; Drug Synergism; Gene Knockdown Techniques; Green Fluorescent Proteins; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Internal Ribosome Entry Sites; Mutant Proteins; Naphthalimides; Phenylenediamines; Polypyrimidine Tract-Binding Protein; Protein Biosynthesis; Protein Transport; Ribavirin; RNA, Messenger; RNA, Small Interfering; RNA, Viral; Sulfonamides; Virus Replication | 2016 |